Page last updated: 2024-10-27

fluconazole and Carcinoma, Non-Small Cell Lung

fluconazole has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Research Excerpts

ExcerptRelevanceReference
" To predict the potential influence of different triazoles (voriconazole, fluconazole, and itraconazole) on the pharmacokinetics of crizotinib by modeling and simulation the physiologically based pharmacokinetic models were established and validated in virtual cancer subjects through Simcyp software based on the essential physicochemical properties and pharmacokinetic data collected."1.72Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib. ( Chen, L; Chen, W; Li, L, 2022)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Chen, L1
Li, L1
Chen, W1
Fu, Y1
Li, Y1
Ma, Y1
He, X1
Xun, X1
Cui, Y1
Fan, L1
Dong, Z1
Zhang, Y1
Zhang, SX1
Trivedi, J1
Toll, AD1
Brahmer, J1
Hales, R1
Bonerigo, S1
Zeng, M1
Li, H1
Yung, RC1

Reviews

1 review available for fluconazole and Carcinoma, Non-Small Cell Lung

ArticleYear
Pleural fluid secondary to pulmonary cryptococcal infection: a case report and review of the literature.
    BMC infectious diseases, 2019, Aug-12, Volume: 19, Issue:1

    Topics: Administration, Oral; Aged; Antifungal Agents; Carcinoma, Non-Small-Cell Lung; Cryptococcosis; Crypt

2019

Other Studies

2 other studies available for fluconazole and Carcinoma, Non-Small Cell Lung

ArticleYear
Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib.
    Clinical pharmacology in drug development, 2022, Volume: 11, Issue:6

    Topics: Antifungal Agents; Carcinoma, Non-Small-Cell Lung; Crizotinib; Fluconazole; Humans; Itraconazole; Lu

2022
Effects of voriconazole and fluconazole on the pharmacokinetics of almonertinib in rats by UPLC-MS/MS.
    Biomedical chromatography : BMC, 2023, Volume: 37, Issue:1

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Chromatography, High Pressure Liquid; Chromatography, Liqui

2023